Validation of three‐dimensional laser scanning for the assessment of facial fat changes

We aimed to evaluate the accuracy of three‐dimensional laser scanning as an objective method for detecting facial changes.

[1]  Y. Sitoh,et al.  Changes in Facial Fat in HIV-Related Lipoatrophy, Wasting, and Weight Gain Measured by Magnetic Resonance Imaging , 2007, HIV clinical trials.

[2]  D. Cooper,et al.  Evaluation of the HIV Lipodystrophy Case Definition in a Placebo-Controlled, 144-Week Study in Antiretroviral-Naive Adults , 2005, Antiviral Therapy.

[3]  B. Gazzard,et al.  British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005) , 2005, HIV medicine.

[4]  S. Richmond,et al.  Reliability of measuring facial morphology with a 3-dimensional laser scanning system. , 2005, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[5]  Nicholas I Paton,et al.  Laser scanning as a tool for assessment of HIV‐related facial lipoatrophy: evaluation of accuracy and reproducibility , 2005, HIV medicine.

[6]  Y. Sitoh,et al.  Facial Fat Volume in HIV-Infected Patients with Lipoatrophy , 2005, Antiviral therapy.

[7]  B. Gazzard.  British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005) , 2005 .

[8]  M. Echavez,et al.  Relationship between lipoatrophy and quality of life. , 2005, The AIDS reader.

[9]  R. Porcher,et al.  Treatment of Facial Lipoatrophy With Intradermal Injections of Polylactic Acid in HIV-Infected Patients , 2005, Journal of acquired immune deficiency syndromes.

[10]  F. Gutiérrez,et al.  Single-slice computed tomography and anthropometric skinfold analysis for evaluation of facial lipoatrophy in HIV-infected patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  S. Azen,et al.  Highly Purified 1000‐cSt Silicone Oil for Treatment of Human Immunodeficiency Virus‐Associated Facial Lipoatrophy: An Open Pilot Trial , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[12]  M W Vannier,et al.  Craniofacial measurements based on 3D-CT volume rendering: implications for clinical applications. , 2004, Dento maxillo facial radiology.

[13]  D. Cooper,et al.  Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study , 2004, AIDS.

[14]  L. Lysakova,et al.  A randomized open‐label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection , 2004, HIV medicine.

[15]  Philippe Katz,et al.  Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA , 2003, AIDS.

[16]  V. Sauret,et al.  Overcoming subjectivity in assessing facial lipoatrophy: is there a role for three‐dimensional laser scans? , 2003, HIV medicine.

[17]  Chiarella Sforza,et al.  Growth and aging of facial soft tissues: A computerized three‐dimensional mesh diagram analysis , 2003, Clinical anatomy.

[18]  C. Moore,et al.  Randomized, Controlled, 48‐Week Study of Switching Stavudine and/or Protease Inhibitors to Combivir/Abacavir to Prevent or Reverse Lipoatrophy in HIV‐Infected Patients , 2003, Journal of acquired immune deficiency syndromes.

[19]  B. Gazzard,et al.  A 48‐Week, Randomized, Open‐Label Comparison of Three Abacavir‐Based Substitution Approaches in the Management of Dyslipidemia and Peripheral Lipoatrophy , 2003, Journal of acquired immune deficiency syndromes.

[20]  C. Taylor,et al.  A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals , 2003, Sexually transmitted infections.

[21]  A. Carr.  An objective case definition of lipodystrophy in HIV-infected adults: a case-control study , 2003, The Lancet.

[22]  J. Carruthers,et al.  HIV‐Associated Facial Lipoatrophy , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[23]  M. Talmor,et al.  Facial Atrophy in HIV-Related Fat Redistribution Syndrome: Anatomic Evaluation and Surgical Reconstruction , 2002, Annals of plastic surgery.

[24]  British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy , 2000 .

[25]  M. Soncul,et al.  The reproducibility of the head position for a laser scan using a novel morphometric analysis for orthognathic surgery. , 2000, International journal of oral and maxillofacial surgery.

[26]  Lipodystrophy syndrome in patients with HIV infection , 1999 .

[27]  I Wilson,et al.  An investigation of laser scanning techniques for quantifying changes in facial soft-tissue volume. , 1997, The New Zealand dental journal.

[28]  R J Wilks,et al.  An optical system for measuring surface shapes for radiotherapy planning. , 1993, The British journal of radiology.